|
|
||||||||
Eur J Cardiothorac Surg 2005;28:200-205
© 2005 Elsevier Science NL
Original articles |
a King Faisal Heart Institute at King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, MBC-16, Riyadh 11211, Saudi Arabia
b The International Heart Institute of Montana Foundation, Missoula, MT, USA
Received 27 December 2004; received in revised form 20 April 2005; accepted 20 April 2005.
* Corresponding author. Tel.: +966 1 442 7470; fax: +966 1 442 7482. (Email: alhalees{at}kfshrc.edu.sa).
Abstract
Objective: There is lack of information regarding the long-term behavior of aortic valve reconstruction with pericardium (AoR). A 16-year follow-up is reported here. Methods: Between 1988 and 1995, 92 consecutive patients had AoR with bovine (Group I, n=27) or glutaraldehyde-treated autologous pericardium (Group II, n=65). The mean age was 30 years (range 1268). There were 65% males, 92% in sinus rhythm, 84% had rheumatic etiology and 36% had other valve surgery. Mitral valve replacement with a mechanical prosthesis is a contraindication to the operation. Results: Hospital mortality was 2%. The reconstructed aortic valve performed well with excellent hemodynamics. The mean follow-up interval was 10.5±4 years, range 916 years (longer for group I,12 versus 10 years) with 4% late deaths and seven patients lost to follow-up. Survival rate was 85±4%. There were no episodes of thromboembolism. Freedom from reoperation for the whole group was 68±5% at 10 years and 47±6% at 16 years. For group I, it was 68±9% at 10 years and 48±10% at 16 years, while for group II it was 72±6 and 45±8% at 10 and 15 years, respectively. Excluding endocarditis (one in group I and seven in group II) and other reasons for reoperation (two in group I and three in group II), the freedom from structural valve degeneration (SVD) at 10 and 16 years was 78±1 and 55±10% for group I. For group II, it was 80±5% at 10 years and 58±9% at 15 years. The mean interval at which the valve degenerated was 8.8 years±3.6 and did not differ between the two groups. Conclusions: AoR is feasible with good hemodynamics, low mortality and thromboembolic rate. Its behavior at 10 years is comparable to that of stentless aortic valve bioprosthesis. It can be performed with either xenopericardium or glutaraldehyde-treated autologous pericardium, but the latter has the advantage of being inexpensive and readily available.
Key Words: Aortic valve Pericardium Valve reconstruction
This article has been cited by other articles:
![]() |
H.-J. Schafers, D. Aicher, S. Riodionycheva, A. Lindinger, T. Radle-Hurst, F. Langer, and H. Abdul-Khaliq Bicuspidization of the unicuspid aortic valve: a new reconstructive approach. Ann. Thorac. Surg., June 1, 2008; 85(6): 2012 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lansac, I. Di Centa, F. Raoux, N. A. Attar, C. Acar, T. Joudinaud, and R. Raffoul A lesional classification to standardize surgical management of aortic insufficiency towards valve repair Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 872 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Goetz, T. E. Tan, K. H. Lim, S. L. H. Salgues, N. Grousson, F. Xiong, Y. L. Chua, and J. H. Yeo Truly stentless molded autologous pericardial aortic valve prosthesis with single point attached commissures in a sheep model Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 548 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Bacha, D. B. McElhinney, K. J. Guleserian, S. D. Colan, R. A. Jonas, P. J. del Nido, and G. R. Marx Surgical aortic valvuloplasty in children and adolescents with aortic regurgitation: Acute and intermediate effects on aortic valve function and left ventricular dimensions J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 552 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Goetz, T. E. Tan, K. H. Lim, F. Xiong, S. L. H. Salgues, N. Grousson, Y. L. Chua, and J. H. Yeo Autologous pericardial pulmonary conduit with single point attached commissures in a sheep model Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 48 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. David Aortic Valve Repair and Aortic Valve Sparing Operations Card. Surg. Adult, January 1, 2008; 3(2008): 935 - 948. [Full Text] |
||||
![]() |
D. Aicher, F. Langer, O. Adam, D. Tscholl, H. Lausberg, and H.-J. Schafers Cusp repair in aortic valve reconstruction: Does the technique affect stability? J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1533 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hawkins, P. C. Kouretas, R. Holubkov, R. V. Williams, L. Y. Tani, J. T. Su, L. M. Lambert, C. R. Mart, M. D. Puchalski, and L. L. Minich Intermediate-term results of repair for aortic, neoaortic, and truncal valve insufficiency in children J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1311 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J De La Zerda, O. Cohen, M. C. Fishbein, J. Odim, C. A Calderon, D. Hekmat, I. Dinov, and H. Laks Aortic valve-sparing repair with autologous pericardial leaflet extension has a greater early re-operation rate in congenital versus acquired valve disease Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 256 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Alsoufi, T. Karamlou, T. Bradley, W. G. Williams, G. S. Van Arsdell, J. G. Coles, J. Smallhorn, M. Nii, V. Guerra, and C. A. Caldarone Short and midterm results of aortic valve cusp extension in the treatment of children with congenital aortic valve disease. Ann. Thorac. Surg., October 1, 2006; 82(4): 1292 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Lausberg, D. Aicher, F. Langer, and H.-J. Schafers Aortic valve repair with autologous pericardial patch. Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 244 - 249. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |